MedDataX Logo

Evaluation of the Impact of Participation in a Psycho-education Program for Victims of Sexual Violence

NCT ID: NCT06718387

Last Updated: 2024-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the impact of a psycho-education program for victims of sexual violence, to determine the most efficient model to patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In 2022, CRP Sud NA set up a psycho-education group for victims of sexual violence (PE-VVS). Two groups were held, involving 10 patients:

* Average age = 35 (29-50)
* Average PCL5 before PE-VSS = 53 (31 - 63)
* Type of SV experienced

* In childhood or adolescence outside family environment
* Incest
* Rape in adulthood outside intimate relationship
* Rape by intimate partner A special feature of this therapeutic group is the involvment of the CRP's patient-partner. He took part in both design and facilitation of the sessions, along with the two CRP co-therapists (IDE / psychologist).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ptsd Sexual Violence Therapeutic Alliance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Without group intervention

Patient refusing group care and/or assessment ended after the inclusion end dates

Group Type NO_INTERVENTION

No interventions assigned to this group

With group intervention

Patient in agreement with group management and available for participation

Group Type EXPERIMENTAL

PsychoEducation Program

Intervention Type OTHER

6 sessions of PsychoEducational Program

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PsychoEducation Program

6 sessions of PsychoEducational Program

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At the suggestion of CRP therapists,
* Patient treated at the CRP having been exposed to sexual violence

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Charles Perrens, Bordeaux

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chantal BERGEY

Role: PRINCIPAL_INVESTIGATOR

Charles Perrens

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Charles PERRENS

Bordeaux, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chantal BERGEY, MD

Role: CONTACT

Phone: 05 56 56 35 78

Email: [email protected]

Celine PELEAU

Role: CONTACT

Phone: 05 56 56 35 78

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chantal BERGEY, MD

Role: primary

Celine PELEAU

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Millon EM, Shors TJ. Taking neurogenesis out of the lab and into the world with MAP Train My Brain. Behav Brain Res. 2019 Dec 30;376:112154. doi: 10.1016/j.bbr.2019.112154. Epub 2019 Aug 14.

Reference Type BACKGROUND
PMID: 31421141 (View on PubMed)

Shors TJ, Millon EM. Sexual trauma and the female brain. Front Neuroendocrinol. 2016 Apr;41:87-98. doi: 10.1016/j.yfrne.2016.04.001. Epub 2016 Apr 13.

Reference Type BACKGROUND
PMID: 27085856 (View on PubMed)

Shors TJ, Olson RL, Bates ME, Selby EA, Alderman BL. Mental and Physical (MAP) Training: a neurogenesis-inspired intervention that enhances health in humans. Neurobiol Learn Mem. 2014 Nov;115:3-9. doi: 10.1016/j.nlm.2014.08.012. Epub 2014 Sep 9.

Reference Type BACKGROUND
PMID: 25219804 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CR-BDX-AP 2023-08

Identifier Type: -

Identifier Source: org_study_id